中文 | English
Return
Total: 1621 , 1/163
Show Home Prev Next End page: GO
Author:(feng Lu ZHANG)

1.Factors related to duration of serum HBsAg in patients with acute hepatitis B

Jiawei ZHANG ; Feng LU

Journal of Clinical Hepatology 2014;30(11):1173-1175

2.Phacoemulsification combined with pars plana vitrectomy for eyes with cataract and proliferative diabetic retinopathy

Hai LU ; Feng ZHANG

Ophthalmology in China 1993;0(03):-

3.Influence of Clinical Tutors' Personality on Medical Ethics Formation of Medical Interns

Feng ZHANG ; Yan LU

Chinese Medical Ethics 1995;0(03):-

4.Study of index for mammogram database

li-feng, ZHANG ; lu, ZHANG

Journal of Shanghai Jiaotong University(Medical Science) 2006;0(05):-

5.Preventive effects of aldose reductase inhibitor AL-1576 on galactose cataract in rat

Yu-feng, ZHANG ; Jian, ZHOU ; Zi-feng, ZHANG ; Lu, LU

Chinese Journal of Experimental Ophthalmology 2012;30(6):495-499

6.Findings and pathological characteristics of rat galactose cataract model

Yu-feng, ZHANG ; Jian, ZHOU ; Lu, LU

Chinese Journal of Experimental Ophthalmology 2011;29(6):489-494

7.Autophagy inhibition enhances radiosensitivity of esophageal squamous carcinoma Eca-109 cells

Chi LU ; Zhang LEI ; Qiong FENG ; Ting LU ; Hongda LU

Chinese Journal of Radiological Medicine and Protection 2015;35(3):165-170

8.Study on working concentration of PDL in primary culture of rat hippocampal neuron

Lu HAN ; Feng XIAO ; Xiumei ZHANG

Chinese Journal of Biochemical Pharmaceutics 2015;37(5):37-39

9.Iron homeostasis and diagnosis of hereditary iron overload: reports from the 56th American Society of Hematology annual meeting

Xudong TANG ; Lu ZHANG ; Feng LIU

Journal of Leukemia & Lymphoma 2015;24(1):46-49

10.Progress of guidelines for quantifying iron overload: reports from the 56th American Society of Hematology annual meeting

Xudong TANG ; Lu ZHANG ; Feng LIU

Journal of Leukemia & Lymphoma 2015;24(2):85-87

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1621 , 1/163 Show Home Prev Next End page: GO